F. X. Bosch, A. Lorincz, and N. Muñoz, The causal relation between human papillomavirus and cervical cancer, J Clin Pathol, vol.55, pp.244-65, 2002.

J. M. Walboomers, M. V. Jacobs, and M. M. Manos, Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J Pathol, vol.189, pp.12-19, 1999.

. Globocan, Estimated cancer incidence, mortality and prevalence worldwide in 2012, p.31, 2016.

L. Denny, M. Quinn, and R. Sankaranarayanan, Chapter 8: screening for cervical cancer in developing countries, Vaccine, vol.24, issue.3, pp.71-77, 2006.

, Comprehensive cervical cancer control: a guide to essential practice, p.12, 2014.

N. Santesso, R. A. Mustafa, and H. J. Schünemann, World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer, Int J Gynaecol Obstet, vol.132, pp.252-260, 2016.

J. Fokom-domgue, C. Combescure, and V. Fokom-defo, Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies, BMJ, vol.351, p.3084, 2015.

M. Arbyn, R. Sankaranarayanan, and R. Muwonge, Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India, Int J Cancer, vol.123, pp.153-60, 2008.

R. Sankaranarayanan, A. Nessa, and P. O. Esmy, Visual inspection methods for cervical cancer prevention, Best Pract Res Clin Obstet Gynaecol, vol.26, pp.221-253, 2012.

R. Sankaranarayanan, B. M. Nene, and S. S. Shastri, HPV screening for cervical cancer in rural India, N Engl J Med, vol.360, pp.1385-94, 2009.

S. De-sanjose, W. G. Quint, and L. Alemany, Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study, Lancet Oncol, vol.11, pp.1048-56, 2010.

R. W. Peeling, K. K. Holmes, and D. Mabey, Rapid tests for sexually transmitted infections (STIs): the way forward, Sex Transm Infect, vol.82, issue.5, pp.1-6, 2006.

V. Bouvard, R. Baan, and K. Straif, On behalf of the WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogenspart B: biological agents, Lancet Oncology, vol.10, pp.321-323, 2009.

P. F. Whiting, A. W. Rutjes, and M. E. Westwood, QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies, Ann Intern Med, vol.155, pp.529-565, 2011.

J. B. Reitsma, A. S. Glas, and A. W. Rutjes, Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews, J Clin Epidemiol, vol.58, pp.982-90, 2005.

J. P. Higgins and S. G. Thompson, Quantifying heterogeneity in a meta-analysis, Stat Med, vol.21, pp.1539-58, 2002.

C. M. Rutter and C. A. Gatsonis, A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations, Stat Med, vol.20, pp.2865-84, 2001.

D. Moher, A. Liberati, and J. Tetzlaff, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ, vol.339, p.2535, 2009.

D. F. Stroup, J. A. Berlin, and S. C. Morton, Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group, JAMA, vol.283, pp.2008-2020, 2000.

Y. L. Qiao, J. W. Sellors, and P. S. Eder, A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China, Lancet Oncol, vol.9, pp.929-965, 2008.

J. C. Gage, K. O. Ajenifuja, and N. Wentzensen, Effectiveness of a simple rapid human papillomavirus DNA test in rural Nigeria, Int J Cancer, vol.131, pp.2903-2912, 2012.

F. H. Zhao, J. Jeronimo, and Y. L. Qiao, An evaluation of novel, lower-cost molecular screening tests for human papillomavirus in rural China, Cancer Prev Res, vol.6, pp.938-986, 2013.

J. Jeronimo, P. Bansil, and J. Lim, A multicountry evaluation of careHPV testing, visual inspection with acetic acid, and Papanicolaou testing for the detection of cervical cancer, Int J Gynecol Cancer, vol.24, pp.576-85, 2014.

M. Segondy, H. Kelly, and M. P. Magooa, Performance of careHPV for detecting highgrade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study, Br J Cancer, vol.115, pp.425-455, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01844576

C. J. Chibwesha, B. Frett, and K. Katundu, Clinical performance validation of 4 pointof-care cervical cancer screening tests in HIV-infected women in Zambia, J Low Genit Tract Dis, vol.20, pp.218-241, 2016.

G. Tuerxun, A. Yukesaier, and L. Lu, Evaluation of careHPV, Cervista Human Papillomavirus, and Hybrid Capture 2 methods in diagnosing cervical intraepithelial neoplasia grade 2+ in Xinjiang Uyghur women, Oncologist, vol.21, pp.825-856, 2016.

P. Bansil, J. Lim, and J. Byamugisha, Performance of cervical cancer screening techniques in HIV-infected women in Uganda, J Low Genit Tract Dis, vol.19, pp.215-224, 2015.

M. Arbyn, G. Ronco, and A. Anttila, Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer, Vaccine, vol.30, issue.5, pp.88-99, 2012.

M. Arbyn, P. J. Snijders, and C. J. Meijer, Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?, Clin Microbiol Infect, vol.21, pp.817-843, 2015.

L. Denny, S. De-sanjose, and M. Mutebi, Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries, Lancet, p.389, 2017.

L. Gaffikin, P. D. Blumenthal, and M. Emerson, Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project, Lancet, vol.361, pp.814-834, 2003.

P. D. Blumenthal, L. Gaffikin, and S. Deganus, Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana, Am J Obstet Gynecol, vol.196, pp.407-408, 2007.

G. P. Parham, M. H. Mwanahamuntu, and S. Kapambwe, Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia, PLoS One, vol.10, p.122169, 2015.

C. Firnhaber, N. Mayisela, and L. Mao, Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa, PLoS One, vol.8, p.53494, 2013.

P. Giorgi-rossi, S. Franceschi, and G. Ronco, HPV prevalence and accuracy of HPV testing to detect high-grade cervical intraepithelial neoplasia, Int J Cancer, vol.130, pp.1387-94, 2012.

M. J. Huchko, H. Leslie, and J. Sneden, Risk factors for cervical precancer detection among previously unscreened HIV-infected women in Western Kenya, Int J Cancer, vol.134, pp.740-745, 2014.

H. A. Kelly, B. Sawadogo, and A. Chikandiwa, Epidemiology of high-risk human papillomavirus and cervical lesions in african women living with HIV/AIDS: effect of anti-retroviral therapy, AIDS, 2016.

D. Konopnicki, Y. Manigart, and C. Gilles, Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women, J Infect Dis, vol.207, pp.1723-1732, 2013.

M. Arbyn, F. Verdoodt, and P. J. Snijders, Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis, Lancet Oncol, vol.15, pp.172-83, 2014.

L. A. Trope, B. Chumworathayi, and P. D. Blumenthal, Feasibility of community-based careHPV for cervical cancer prevention in rural Thailand, J Low Genit Tract Dis, vol.17, pp.315-324, 2013.

A. J. Rosenbaum, J. C. Gage, and K. M. Alfaro, Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador, Int J Gynaecol Obstet, vol.126, pp.156-60, 2014.

D. Obiri-yeboah, Y. Adu-sarkodie, and F. Djigma, Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women. BMC Women's Health, 2017.

J. Sinayobye, M. Sklar, and D. R. Hoover, Prevalence and risk factors for High-Risk Human Papillomavirus (hrHPV) infection among HIV-infected and uninfected Rwandan women: implications for hrHPV-based screening in Rwanda, Infect Agent Cancer, vol.9, p.40, 2014.

G. Koliopoulos, M. Arbyn, and P. Martin-hirsch, Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and metaanalysis of non-randomized studies, Gynecol Oncol, vol.104, pp.232-278, 2007.

P. E. Castle, K. M. Smith, and T. E. Davis, Reliability of the Xpert HPV assay to detect highrisk human papillomavirus DNA in a colposcopy referral population, Am J Clin Pathol, vol.143, pp.126-159, 2015.

K. Cuschieri, D. Geraets, and J. Cuzick, Performance of a cartridge-based assay for detection of clinically significant human papillomavirus (HPV) infection: lessons from VALGENT (Validation of HPV genotyping tests), group.bmj.com on December 9, vol.54, pp.2337-2379, 2016.